🇺🇸 Emtricitabine plus adefovir dipivoxil in United States

Emtricitabine plus adefovir dipivoxil (Emtricitabine plus adefovir dipivoxil) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Emtricitabine plus adefovir dipivoxil in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Emtricitabine plus adefovir dipivoxil approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Emtricitabine plus adefovir dipivoxil in United States?

Asian-Pacific Alliance of Liver Disease, Beijing is the originator. The local marketing authorisation holder may differ — check the official source linked above.